• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组胺H3受体拮抗剂与人肾上腺细胞色素P450酶的协同作用。

Coordination of histamine H3 receptor antagonists with human adrenal cytochrome P450 enzymes.

作者信息

Yang Richard, Hey John A, Aslanian Robert, Rizzo Charles A

机构信息

Schering-Plough Research Institute, Allergy, Kenilworth, NJ 07033, USA.

出版信息

Pharmacology. 2002 Nov;66(3):128-35. doi: 10.1159/000063794.

DOI:10.1159/000063794
PMID:12372902
Abstract

Optical difference spectroscopy was used to identify and quantify human adrenal microsomal and mitochondrial cytochrome P450 enzyme interactions with the histamine H(3) receptor antagonists thioperamide, clobenpropit and ciproxifan. Addition of these structurally diverse imidazole H(3) receptor antagonists to cytochrome-P450-containing human adrenal microsomal and mitochondrial preparations resulted in concentration-dependent type II optical difference spectra. Respective spectral dissociation constants (K(S)) for the drug interactions with human adrenal microsomal and mitochondrial cytochrome P450 were 1.5 and 1.6 micromol/l for thioperamide, 3.1 and 0.28 micromol/l for clobenpropit and 0.10 and 0.11 micromol/l for ciproxifan. The three compounds demonstrated a similar activity profile in cytochrome-P450-containing bovine adrenal microsomal and mitochondrial preparations. Findings indicate direct coordination of these imidazole-containing H(3) receptor antagonists with the heme moiety of human adrenal cytochrome P450 isozymes.

摘要

利用光学差示光谱法来鉴定和定量人肾上腺微粒体及线粒体细胞色素P450酶与组胺H(3)受体拮抗剂硫代哌啶、氯苯丙哌嗪和西普司特之间的相互作用。将这些结构各异的咪唑H(3)受体拮抗剂添加到含细胞色素P450的人肾上腺微粒体及线粒体制剂中,会产生浓度依赖性的II型光学差示光谱。硫代哌啶与人肾上腺微粒体及线粒体细胞色素P450药物相互作用的各自光谱解离常数(K(S))分别为1.5和1.6微摩尔/升,氯苯丙哌嗪为3.1和0.28微摩尔/升,西普司特为0.10和0.11微摩尔/升。这三种化合物在含细胞色素P450的牛肾上腺微粒体及线粒体制剂中表现出相似的活性特征。研究结果表明,这些含咪唑的H(3)受体拮抗剂与人肾上腺细胞色素P450同工酶的血红素部分直接配位。

相似文献

1
Coordination of histamine H3 receptor antagonists with human adrenal cytochrome P450 enzymes.组胺H3受体拮抗剂与人肾上腺细胞色素P450酶的协同作用。
Pharmacology. 2002 Nov;66(3):128-35. doi: 10.1159/000063794.
2
H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450.H3受体拮抗剂硫代丙酰胺可抑制肾上腺类固醇生成,抑制组胺与肾上腺皮质微粒体的结合,并与细胞色素P450结合。
Br J Pharmacol. 1992 Sep;107(1):161-4. doi: 10.1111/j.1476-5381.1992.tb14480.x.
3
Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.非咪唑类H3受体拮抗剂缺乏致僵增强作用,揭示了基于咪唑的H3受体拮抗剂与抗精神病药物之间潜在的药物相互作用。
Brain Res. 2005 May 31;1045(1-2):142-9. doi: 10.1016/j.brainres.2005.03.018. Epub 2005 Apr 20.
4
Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists.用哌啶部分取代咪唑对组胺H3受体拮抗剂的效力有不同影响。
Naunyn Schmiedebergs Arch Pharmacol. 2003 Jan;367(1):43-50. doi: 10.1007/s00210-002-0649-4. Epub 2002 Nov 14.
5
Influence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonists.
Eur J Pharm Sci. 2001 Jun;13(3):249-59. doi: 10.1016/s0928-0987(01)00106-3.
6
In vitro characterization of potency, affinity and selectivity of H3-antagonists: from thioperamide to thioperamide unrelated imidazole derivatives.H3拮抗剂的效价、亲和力和选择性的体外特性:从硫代哌酰胺到与硫代哌酰胺无关的咪唑衍生物
Farmaco. 1997 Jun-Jul;52(6-7):463-9.
7
Interaction of metyrapone with adrenal microsomal cytochrome P450 in the guinea pig.
Biochem Pharmacol. 1978;27(17):2147-51. doi: 10.1016/0006-2952(78)90287-3.
8
Synthesis and evaluation of a new series of 1'-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4'-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonists.合成和评价一系列新型 1'-环丁基-6-(4-哌啶氧基)螺[苯并吡喃-2,4'-哌啶]衍生物作为高亲和力和选择性组胺-3 受体(H3R)拮抗剂。
Bioorg Med Chem Lett. 2012 Mar 15;22(6):2151-3. doi: 10.1016/j.bmcl.2012.01.139. Epub 2012 Feb 8.
9
Medicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists.
Mini Rev Med Chem. 2004 Nov;4(9):965-77. doi: 10.2174/1389557043403107.
10
Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.两种新型选择性非咪唑类组胺H3受体拮抗剂A-304121和A-317920:I. 体外药理作用
J Pharmacol Exp Ther. 2003 Jun;305(3):887-96. doi: 10.1124/jpet.102.047183. Epub 2003 Feb 20.

引用本文的文献

1
The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?氯苯丙哌及趋化因子受体4(CXCR4)的故事:能否成为治疗癌症和自身免疫性疾病的有效药物?
Front Pharmacol. 2024 Jul 12;15:1410104. doi: 10.3389/fphar.2024.1410104. eCollection 2024.
2
Structure-Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands.以开发选择性组胺受体配体为目标的杂芳基丙基胍类化合物的构效关系
ChemistryOpen. 2019 Mar 5;8(3):285-297. doi: 10.1002/open.201900011. eCollection 2019 Mar.
3
4-Hydroxypiperidines and Their Flexible 3-(Amino)propyloxy Analogues as Non-Imidazole Histamine H₃ Receptor Antagonist: Further Structure⁻Activity Relationship Exploration and In Vitro and In Vivo Pharmacological Evaluation.
4-羟基哌啶及其柔性 3-(氨基)丙氧基类似物作为非咪唑组胺 H₃受体拮抗剂:进一步的结构-活性关系探索及体外和体内药理学评价。
Int J Mol Sci. 2018 Apr 19;19(4):1243. doi: 10.3390/ijms19041243.
4
Hybrid approach to structure modeling of the histamine H3 receptor: Multi-level assessment as a tool for model verification.组胺H3受体结构建模的混合方法:作为模型验证工具的多层次评估。
PLoS One. 2017 Oct 5;12(10):e0186108. doi: 10.1371/journal.pone.0186108. eCollection 2017.
5
Histamine H3 receptor antagonist JNJ-39220675 modulates locomotor responses but not place conditioning by dopaminergic drugs.组胺H3受体拮抗剂JNJ - 39220675可调节运动反应,但不影响多巴胺能药物的位置条件反射。
Psychopharmacology (Berl). 2015 Mar;232(6):1143-53. doi: 10.1007/s00213-014-3751-7. Epub 2014 Oct 12.
6
Histamine: an undercover agent in multiple rare diseases?组胺:多种罕见疾病的卧底特工?
J Cell Mol Med. 2012 Sep;16(9):1947-60. doi: 10.1111/j.1582-4934.2012.01566.x.
7
Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions.H3受体反向激动剂硫代哌酰胺对可卡因诱导的小鼠运动的影响:组胺能系统的作用及潜在的药代动力学相互作用
Psychopharmacology (Berl). 2009 Mar;202(4):673-87. doi: 10.1007/s00213-008-1345-y. Epub 2008 Oct 9.
8
Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.利用新型、选择性、非咪唑类组胺H3受体反向激动剂放射性配体[3H]A-349821检测多种H3受体亲和力状态。
Br J Pharmacol. 2006 Jul;148(5):657-70. doi: 10.1038/sj.bjp.0706752. Epub 2006 May 22.
9
Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels.有机阳离子转运体3通过控制细胞内组胺水平来调节小鼠嗜碱性粒细胞功能。
J Exp Med. 2005 Aug 1;202(3):387-93. doi: 10.1084/jem.20050195.